Research Studies
Back to Results
The effect of topiramate on etonogestrel concentrations in contraceptive implant users
Details
Age
Adult
Eligibility
Healthy, reproductive-aged females who have had the ENG implant between one and three years
Phase
IV - Research Studies occurring after FDA has approved a drug for marketing. These studies gather additional information about a drug's safety, efficacy, or optimal use.
Type of Study
Other
Locations
Comprehensive Women's Health Center
Comprehensive Womens Health Center
University of Colorado Hospital
Principal Investigator
Stephanie Teal, MD
Study ID
Protocol Number: 17-1047
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers